FGFR1 and ductal breast carcinoma in situ: The frequency of FGFR1 amplification has been shown to be higher in invasive breast carcinomas and in the invasive components of tumors with both invasive and ductal carcinomas in situ (DCIS) components compared to pure DCIS [9].